Introduction
============

Atrial fibrillation (AF) is one of the most common clinical arrhythmias and easily complicated by cardiac insufficiency and thromboembolic complications, which seriously affect the patients' quality of life. The occurrence and maintenance mechanism of AF is not very clear at present. Some studies reported that the structural and electrophysiological basis of the occurrence of AF might be the left atrial reentrant micro ring and enlarged left atrium.[@b1-cia-10-813] Some researchers found that elevated plasma high-sensitive C-reactive protein (hs-CRP) level was an independent risk factor for AF, which indicated that chronic inflammation seemed to play an important role in the development of AF.[@b2-cia-10-813] A study from the digestion department of internal medicine (Beijing Mentougou District Hospital, Beijing China) showed that the *Helicobacter pylori* (Hp) infection rate was as high as 50% in Chinese adults, and Hp was not only an important pathogenic reason for chronic gastritis and stomach cancer but also closely related to the occurrence of non-gastrointestinal diseases.[@b3-cia-10-813]

Some studies showed that chronic Hp infection was involved in AF and it played an important role in the development of AF,[@b4-cia-10-813]--[@b8-cia-10-813] but others demonstrated that Hp infection was not correlated with AF.[@b9-cia-10-813]--[@b11-cia-10-813] However, these studies had relatively small sample sizes, and none of the patients have been classified into different AF-type categories in accordance with the guidelines to further explore the correlation between Hp infection and different types of AF. The purpose of this study was to clarify the relationship between Hp infection and the different types of AF, and to investigate the occurrence and maintenance mechanism of AF.

Materials and methods
=====================

Subjects
--------

This study consisted of a retrospective analysis of a single-site cohort. The consecutive hospitalized patients with AF (excluding cardiac insufficiency, acute coronary syndrome, thyroid dysfunction, and any infections) in Beijing Tiantan Hospital from January 1, 2007 to April 12, 2013 were selected. The control group came from Health Screening Center during the same period, and their age and sex matched those of the AF group. Subjects who had suffered gastrointestinal bleeding within 1 week; had a history of gastrectomy; used antibiotics, bismuth, or sucralfate within 1 month; had a chronic infection; had obesity; had heart failure; or had other conditions that might increase IL-6 promoting chronic inflammatory response were excluded. There were 110 males (38.6%) and 175 females (61.4%). Patient history, physical examination, and laboratory results were recorded with chart abstraction. Their average age was 63.8±10.8 years. Patients were divided into two groups: the short-standing AF group, in whom the symptoms persisted for less than 1 year, and the long-standing AF group, in whom the symptoms persisted for more than 1 year.

Tests and examinations
----------------------

### Routine examination

All the patients underwent the following tests/examinations on the next day after admission: blood routine, biochemical items, glycosylated hemoglobin, hs-CRP, homocysteine (HCY), ^13^C urea breath, blood coagulation, and ultrasonic cardiogram (UCG).

### ^13^C urea breath test

The ^13^C urea breath test was measured using the HCBT-01 breath test automatic instrument (Shenzhen Zhonghe Haidewei Biological Technology Co. Ltd), and the determination whether patients had Hp infection was calculated by ^13^C/^12^C isotope ratio (*δ *‰). Subjects were asked to fast more than 2 hours before blood tests. The positive value of Hp infection was defined as *δ*≥4‰±0.4‰.

### Hs-CRP and Hp antibody level

Hs-CRP was measured using particle-enhanced immune transmission turbidimetry (DiaSys Diagnostic Systems of GmbH). Hp-IgG antibody was measured by the colloidal gold method (Shanghai Enterasys Biological Technology Co. Ltd).

### UCG examination

UCG examination was performed using the United States GE Vivid 7 ultrasound heartbeat graph diagnosis system. Patients were asked to be in the left lateral position. The parasternal long axis, parasternal short axis, apical four-chamber view, and apical two-chamber view were used. Left ventricular end-diastolic diameter and left atrial diameter (LAD) were measured by using the parasternal long axis view. Biplane Simpson formula was used to quantify left ventricular ejection fraction.

Statistical methods
-------------------

Baseline characteristics of patients were compared using ANOVA for continuous variables and the chi-squared test for non-continuous variables. When continuous data were not normally distributed, groups were compared using nonparametric Wilcoxon rank sum test. The correlation between baseline characteristics and long-standing AF was tested using a univariate logistic regression model. Clinically significant variables were entered into a multivariate regression model. *P*\<0.05 was statistically significant. Statistical analysis was performed using the SPSS software (version 13.0).

Results
=======

The baseline data of each group
-------------------------------

Control group had 300 (51.3%) patients, short-standing AF group had 126 (21.5%) patients, and long-standing AF group had 159 (27.2%) patients. The baseline data of each group are shown in [Table 1](#t1-cia-10-813){ref-type="table"}. There were significant differences in age, heart rate (HR), neutrophils (NEU), LAD, hs-CRP, and HCY among the groups. Patients with long-standing AF were older and had a higher value of HR, NEU, LAD, hs-CRP, and HCY than those with short-standing AF ([Table 1](#t1-cia-10-813){ref-type="table"}).

There were significant differences in the incidence of Hp-negative and Hp-IgG antibody negative (65.0% vs 69.8% vs 12.0%, *P*\<0.001) and Hp-positive and Hp-IgG antibody positive (15.0% vs 18.3% vs 73.6%, *P*\<0.001) among the groups ([Figure 1](#f1-cia-10-813){ref-type="fig"}). There were no significant differences in the incidence of Hp-negative and Hp-IgG antibody positive (7.7% vs 5.6% vs 6.3%, *P*=0.696) and Hp-positive and Hp-IgG antibody negative (18.1% vs 6.4% vs 16.5%, *P*=0.117) among the groups ([Figure 1](#f1-cia-10-813){ref-type="fig"}).

The Hp levels on admission were significantly higher in the long-standing AF group than in the short-standing AF group and control group (*P*\<0.001, *P*\<0.001, respectively; [Table 1](#t1-cia-10-813){ref-type="table"} and [Figure 2](#f2-cia-10-813){ref-type="fig"}).

Comparison of Hp *δ* value, Hs-CRP, and LAD among five groups of AF
-------------------------------------------------------------------

There was a significant difference in Hp *δ* value among the five groups ([Table 2](#t2-cia-10-813){ref-type="table"}) of AF (*P*=0.034). Patients with permanent AF in Group 5 had a significantly higher Hp level than those in Group 1, 2, and 3 (*P*=0.005, 0.012, and 0.038, respectively); there was also a significant difference in hs-CRP value among the five groups (*P*=0.014). The median hs-CRP value of Group 5 was significantly higher than those of Group 1, 2, and 3 (*P*=0.000, 0.025, and 0.006, respectively). The mean LAD value in Group 5 was significantly higher than those in Group 1, 2, 3, and 4 (*P*=0.001, 0.010, 0.014, and 0.034, respectively) ([Table 2](#t2-cia-10-813){ref-type="table"}).

Logistic regression analysis in patients with long-standing AF
--------------------------------------------------------------

The effects of variables in the presence of long-standing AF were determined by univariate and multivariate logistic regression analyses. In univariate analysis, we identified potential variables (age, HR, NEU, LAD, hs-CRP, Hp *δ* value, and HCY) and analyzed them by a multivariate logistic regression model. In multivariate analysis, Hp infection (odds ratio \[OR\] 13.172, 95% confidence interval \[CI\] 7.819--22.191, *P*\<0.001) was still an independent predictor of long-standing AF as well as NEU (*P*\<0.001), hs-CRP (*P*=0.002), and HCY (*P*\<0.001) ([Table 3](#t3-cia-10-813){ref-type="table"}).

The Hosmer--Lemeshow goodness of fit test showed chi-square 8.203, df 8, and *P*-value 0.414, and contingency table for Hosmer and Lemeshow test are shown in [Table 4](#t4-cia-10-813){ref-type="table"}.

Receiver-operating characteristic curves analysis of Hp infection, LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting long-standing AF
----------------------------------------------------------------------------------------------------------------------------------------------------

Hp *δ* value had a 66.7% sensitivity (95% CI 0.733--0.801), 78.4% specificity (95% CI 0.751--0.817), and the best critical value (14.75‰) in predicting long-standing AF (area under the curve \[AUC\] 0.774, [Figure 3](#f3-cia-10-813){ref-type="fig"} and [Table 5](#t5-cia-10-813){ref-type="table"}). LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting longstanding AF are shown in [Figure 3](#f3-cia-10-813){ref-type="fig"} and [Table 5](#t5-cia-10-813){ref-type="table"}.

Discussion
==========

Research about AF began in the last century, but the mechanism of AF still has not been completely clarified to date. In recent years, with the continuous research of chronic Hp infection, the correlation between Hp and non-gastrointestinal diseases gradually entered people's field of vision, especially the relationship between Hp and AF. However, the researchers have not reached an agreement. For example, a case-control study from Montenero in Italy showed that there was a strong correlation between chronic AF and Hp infection,[@b6-cia-10-813] but Lunetta et al did not find correlation between them in Italy population.[@b9-cia-10-813] Furthermore, most of these studies had no further classification for AF. Moreover, some studies only reported the relationship between Hp-IgG antibody and AF. There are great limitations to analyze the correlation between AF and plasma Hp-IgG antibody instead of Hp value, because the positive Hp-IgG antibody only shows that a patient has been infected with Hp previously and it does not reflect the situation in the patient with AF episode. Also, the sensitivity and specificity of Hp-IgG antibody for coronary heart disease are poor.[@b10-cia-10-813]

Considering the exposure of Hp in different ways, this study conducted a subgroup analysis and categorized the individuals as Hp-negative (by both tests), Hp-positive (by both tests), previous Hp (Hp antibody-positive) but not current Hp (^13^C urea breath test-negative), and current Hp (by the breath test). It was found that Hp-positive (by both tests) had a higher rate of long-standing AF than other two groups (short-standing AF group and control group), which indicated that the continuing action of chronic inflammation played an important role in the persistence of AF.

In our study, patients with AF were divided into five groups according to the classification of AF types in the 2012 European Society of Cardiology guidelines, and another classification was based on whether AF was persistent for more than 1 year. The study adopted ^13^C urea breath test to test situation of Hp infection, considering LAD, the level of hs-CRP, and other relevant clinical data, and further analyzed the correlation between Hp infection and AF. Our study found that there was a significant correlation between Hp *δ* value in the five groups. Patients with permanent AF in Group 5 had a higher level of Hp value than those in other groups. Patients with long-standing AF had a higher Hp value than those with short-standing AF. After adjusting for other important covariates in a multivariate regression model, Hp *δ* value ≥4‰ remained an independent predictor for long-standing AF.[@b13-cia-10-813],[@b14-cia-10-813]

More and more evidence has shown that inflammation reaction has been closely related to AF since 1997. Inflammation and AF are inseparable and have interaction and reciprocal causation, although whether the inflammation is the inducement or the secondary outcome of AF has not been determined.[@b13-cia-10-813] CRP is recognized as one of the markers of inflammation. Some researchers have shown that CRP is one of the independent risk factors of AF, baseline CRP level can predict the risk of AF in the future, and CRP can reflect the degree of inflammation, which is closely related to the type and the duration of AF.[@b14-cia-10-813] Our study found that hs-CRP significantly increased in patients with long-standing AF, which was consistent with the results of previous research.[@b13-cia-10-813],[@b14-cia-10-813]

The core part of the development of AF is atrial remodeling, which includes electrical remodeling, functional remodeling, and structural remodeling. Atrial electrical remodeling in patients with long-standing AF is chronic and irreversible, which results in substantial calcium influx, calcium overload, atrial systolic dysfunction, atrial passive extension, and atrial enlargement and further aggravates the functional remodeling and structural remodeling. The three different remodelings reinforce each other in a vicious cycle.[@b13-cia-10-813],[@b14-cia-10-813] The longer the duration of AF, the more obvious the atrial electrical remodeling and structural remodeling. Therefore, the LAD of patients with long-standing AF was significantly larger than those with short-standing AF in our study.

Our study found that the Hp value was significantly increased in patients with long-standing AF. Since inflammation is closely related to AF and Hp infection can lead to chronic inflammation, thus, it is reasonable to believe that there may be some internal relations between Hp infection and AF. On one hand, if patients are infected with Hp, their bodies will produce H^+^/K^+^-ATP enzyme autoantibodies that bind to the H^+^/K^+^-ATP enzyme and then damage the atrial cell pump that makes the ion environment imbalanced and the depolarization delayed, which will trigger attack of AF.[@b7-cia-10-813] On the other hand, Hp will produce cytotoxin-associated protein A (CagA), which will stimulate gastric epithelial cells to produce interleukin-8, induce NEU infiltration, and result in a series of inflammatory reactions. The longer the Hp infection lasts, the greater the CagA toxicity will be sustained and the more severe the atrial muscle cells will be damaged.[@b15-cia-10-813] This long-term chronic persistent inflammation is likely to be the foundation of permanent and long-term persistent AF. The current study also found that Hp-IgG antibodies (which only shows that people were infected with Hp previously) had no correlation with the duration of AF, which also proved the important role of the continuing action of chronic inflammation in the development of AF.

Although the study found Hp infection had a correlation with the duration of AF, it could not confirm that Hp infection induced the long-term AF. So there is the possibility of reverse causality -- individuals with AF, particularly long-term AF, are more susceptible to Hp infection and/or higher values of Hp infection.

Limitations
===========

However, the study had some limitations. On one hand, this study is a retrospective research and has a small sample size. At the other hand, it did not provide detailed information on socioeconomic status because education and income are generally associated with Hp infection and low socioeconomic status may also be associated with AF, although all the subjects came from the same community. Large prospective studies are expected to confirm what we found in the relationship between Hp infection and long-standing AF.
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![Comparison of Hp-positive/Hp-negative and Hp-IgG antibody-positive/Hp-IgG antibody-negative among the groups.\
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![Comparison of Hp levels among the groups (*P*\<0.001).\
**Notes:** The Hp levels on admission were significantly higher in the long-standing AF group than in the short-standing AF group and control group (*P*\<0.001, *P*\<0.001, respectively).\
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![The ROC curves analysis of Hp infection, LAD, NEU, hs-CRP, HCY, and multivariate variables for predicting long-standing AF.\
**Abbreviations:** ROC, receiver-operating characteristic; Hp, *Helicobacter pylori*; LAD, left atrial diameter; NEU, neutrophil; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; AF, atrial fibrillation.](cia-10-813Fig3){#f3-cia-10-813}

###### 

The baseline data of each group

  Group                                        Control group (n=300)   AF group              *P*-value                        
  -------------------------------------------- ----------------------- --------------------- ---------------------- --------- ---------
  Female, n                                    198 (66.0%)             82 (65.1%)            93 (58.5%)             0.256     0.265
  Smoke, n                                     159 (53.0%)             66 (52.4%)            81 (50.9%)             0.809     0.916
  Alcohol, n                                   89 (29.7%)              43 (34.1%)            54 (34.0%)             0.977     0.525
  Hypertension, n                              221 (73.7%)             99 (78.6%)            121 (76.1%)            0.622     0.546
  Dyslipidemia, n                              112 (37.3%)             55 (43.7%)            62 (39.0%)             0.427     0.475
  Diabetes mellitus, n                         90 (30.0%)              32 (25.4%)            54 (34.0%)             0.118     0.293
  Cerebral infarction, n                       82 (27.3%)              37 (29.4%)            54 (34%)               0.408     0.334
  Hematencephalon, n                           7 (1.2%)                5 (0.9%)              4 (0.7%)               0.486     0.628
  Family history of AF, n                      11 (3.7%)               7 (5.6%)              5 (3.1%)               0.314     0.550
  Arteriosclerosis, n                          190 (63.3%)             85 (67.5%)            116 (73.0%)            0.312     0.113
  Fundus abnormal, n                           268 (89.3%)             112 (88.9%)           135 (84.9%)            0.462     0.205
  Mean age ± SD (years)                        60.2±10.65              62.1±11.78            65.1±9.80              0.022     \<0.001
  Mean SBP ± SD (mmHg)                         135±22.3                132±23.1              136±22.3               0.235     0.478
  Mean heart rate/minute                       74±12.3                 76±16.0               79±14.5                0.019     \<0.001
  Mean WBC ± SD (10^9^/L)                      7.3±2.30                7.4±2.50              7.4±2.53               0.851     0.919
  Mean NEU ± SD (10^9^/L)                      4.9±1.44                5.3±1.60              6.3±2.19               \<0.001   \<0.001
  Mean LVEF ± SD (%)                           61.4±10.13              61.9±10.80            60.8±10.55             0.363     0.654
  Mean LAD ± SD (mm)                           32.9±4.45               34.8±4.79             36.7±5.86              0.001     \<0.001
  Mean BMI ± SD (kg/m^2^)                      25.5±3.88               25.2±3.41             25.4±4.16              0.673     0.681
  Median hs-CRP (mg/L) (interquartile range)   8.00 (5.34--12.00)      8.00 (4.87--13.29)    12.60 (7.60--24.00)    0.002     0.003
  Median HCY (μmol/L) (interquartile range)    9.90 (4.57--16.10)      11.90 (9.76--17.20)   12.60 (10.12--20.10)   0.005     \<0.001
  Hp-IgG antibody                              131 (43.7%)             60 (47.6%)            79 (49.7%)             0.238     0.437
  Hp *δ* value (‰)(interquartile range)        6.25 (2.10--13.30)      7.00 (2.10--14.50)    19.00 (8.00--26.00)    \<0.001   \<0.001
  Hp *δ* value ≥4‰                             86 (28.7%)              31 (24.6%)            130 (81.8%)            \<0.001   \<0.001

**Abbreviations:** AF, atrial fibrillation; SD, standard deviation; SBP, systolic blood pressure; WBC, white blood-cell count; NEU, neutrophil; LVEF, left ventricular ejection fraction; LAD, left atrium diameter; BMI, body mass index; hs-CRP, high sensitive C-reactive protein; HCY, homocysteine; Hp, *Helicobacter pylori*.

###### 

Comparing Hp *δ* value, hs-CRP, and LAD among five groups of AF

  Group   Types of AF          n    Hp *δ* value (‰)                                               hs-CRP (mg/L)                                                   LAD ± SD (mm)
  ------- -------------------- ---- -------------------------------------------------------------- --------------------------------------------------------------- -----------------------------------------------------
  1       Initial AF           34   6.35 (1.8--11.4)[\*](#tfn2-cia-10-813){ref-type="table-fn"}    4.30 (1.84--8.01)[\#](#tfn3-cia-10-813){ref-type="table-fn"}    35.9±3.80[▲](#tfn4-cia-10-813){ref-type="table-fn"}
  2       Paroxysmal AF        58   5.25 (1.67--19.3)[\*](#tfn2-cia-10-813){ref-type="table-fn"}   5.58 (3.89--10.27)[\#](#tfn3-cia-10-813){ref-type="table-fn"}   37.1±4.64[▲](#tfn4-cia-10-813){ref-type="table-fn"}
  3       Persistent AF        67   8.40 (2.50--19.0)[\*](#tfn2-cia-10-813){ref-type="table-fn"}   4.94 (2.50--11.56)[\#](#tfn3-cia-10-813){ref-type="table-fn"}   37.3±4.54[▲](#tfn4-cia-10-813){ref-type="table-fn"}
  4       Long persistent AF   76   8.10 (2.43--30.4)                                              5.83 (2.36--14.41)                                              37.6±5.16[▲](#tfn4-cia-10-813){ref-type="table-fn"}
  5       Permanent AF         50   14.9 (4.13--31.0)[\*](#tfn2-cia-10-813){ref-type="table-fn"}   6.81 (5.25--16.68)[\#](#tfn3-cia-10-813){ref-type="table-fn"}   39.5±5.75[▲](#tfn4-cia-10-813){ref-type="table-fn"}

**Notes:**

Patients with permanent AF in Group 5 had a significantly higher Hp level than those in Group 1, 2, and 3.

The median hs-CRP value of Group 5 was significantly higher than those of Group 1, 2, and 3.

The mean LAD value in Group 5 was significantly higher than those in Group 1, 2, 3, and 4.

**Abbreviations:** Hp, *Helicobacter pylori*; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter; AF, atrial fibrillation; SD, standard deviation.

###### 

Predictors of presence of long-standing AF in logistic regression analysis

  Variable               Univariate               Multivariate                            
  ---------------------- ------------------------ -------------- ------------------------ ---------
  Age                    1.040 (1.021--1.058)     \<0.001        1.021 (0.997--1.045)     0.090
  Smoke                  0.928 (0.644--1.336)     0.687          0.956 (0.570--1.603)     0.864
  Hypertension           1.055 (0.689--1.614)     0.806          1.117 (0.634--1.969)     0.701
  Dyslipidemia           0.991 (0.682--1.440)     0.963          0.897 (0.538--1.497)     0.687
  Diabetes mellitus      1.281 (0.868--1.892)     0.212          1.662 (0.352--7.845)     0.521
  Cerebral infarction    1.327 (0.898--1.961)     0.156          0.592 (0.123--2.844)     0.513
  Hematencephalon        0.890 (0.283--2.802)     0.843          2.805 (0.184--42.752)    0.458
  Family history of AF   0.736 (0.269--2.017)     0.551          0.458 (0.042--5.020)     0.523
  Arteriosclerosis       1.351 (0.917--1.991)     0.128          1.563 (0.943--2.592)     0.083
  HR \>100 bpm           2.492 (1.310--4.742)     0.005          1.927 (0.807--4.602)     0.140
  NEU \>8×10^9^/L        5.730 (3.192--10.285)    \<0.001        4.863 (2.338--10.113)    \<0.001
  LAD \>36 mm            2.401 (1.656--3.481)     \<0.001        2.469 (1.526--3.996)     \<0.001
  Hs-CRP \>5 mg/L        2.069 (1.338--3.201)     0.001          2.458 (1.406--4.298)     0.002
  Hp *δ* value ≥4‰       11.724 (7.435--18.487)   \<0.001        13.172 (7.819--22.191)   \<0.001
  HCY ≥15 μmol/L         2.902 (1.993--4.226)     \<0.001        3.203 (1.983--5.173)     \<0.001

**Abbreviations:** AF, atrial fibrillation; OR, odds ratio; CI, confidence interval; HR, heart rate; NEU, neutrophil; LAD, left atrial diameter; hs-CRP, high sensitive C-reactive protein; Hp, *Helicobacter pylori*; HCY, homocysteine.

###### 

Contingency table for Hosmer and Lemeshow test

  Short-standing AF   Long-standing AF   Total            
  ------------------- ------------------ ------- -------- ----
  58                  59.175             2       0.825    60
  57                  57.403             2       1.597    59
  58                  56.585             1       2.415    59
  52                  55.124             7       3.876    59
  53                  52.693             6       6.307    59
  50                  48.439             9       10.561   59
  45                  41.317             15      18.683   60
  32                  30.481             27      28.519   59
  17                  18.094             42      40.906   59
  4                   6.689              48      45.311   52

**Abbreviation:** AF, atrial fibrillation.

###### 

AUC, Se, and Sp

  Test result variable     Area under curve       Se (95% CI)   Sp (95% CI)            The best critical value   
  ------------------------ ---------------------- ------------- ---------------------- ------------------------- -------
  Multivariate variables   0.879 (0.847--0.912)   \<0.001       0.767 (0.733--0.801)   0.850 (0.821--0.879)      0.359
  Hp *δ* value ‰           0.774 (0.729--0.820)   \<0.001       0.667 (0.629--0.705)   0.784 (0.751--0.817)      14.75
  NEU (10^9^/L)            0.669 (0.619--0.720)   \<0.001       0.509 (0.468--0.550)   0.765 (0.731--0.799)      6.25
  HCY (μmol/L)             0.655 (0.608--0.702)   \<0.001       0.541 (0.501--0.581)   0.657 (0.619--0.695)      12.52
  hs-CRP (mg/L)            0.694 (0.643--0.745)   \<0.001       0.447 (0.407--0.487)   0.934 (0.914--0.954)      21.15
  LAD (mm)                 0.662 (0.610--0.714)   \<0.001       0.535 (0.495--0.575)   0.796 (0.763--0.829)      37.10

**Abbreviations:** AUC, area under curve; Se, sensitivity; Sp, specificity; CI, confidence interval; Hp, *Helicobacter pylori*; NEU, neutrophil; HCY, homocysteine; hs-CRP, high sensitive C-reactive protein; LAD, left atrial diameter.
